PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection)

Padma Priya Manapragada; Efstathia Andrikopoulou; Navkaranbir Bajaj; Pradeep Bhambhvani

doi:10.1016/j.rcl.2021.05.009

PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection)

Radiol Clin North Am. 2021 Sep;59(5):835-852. doi: 10.1016/j.rcl.2021.05.009.

Authors

Padma Priya Manapragada¹, Efstathia Andrikopoulou², Navkaranbir Bajaj³, Pradeep Bhambhvani⁴

Affiliations

¹ University of Alabama at Birmingham, 619 19th Street South JT 772, Birmingham, AL 35249, USA.
² University of Alabama at Birmingham, Tinsley Harrison Tower, Suite 311, 1900 University Boulevard, Birmingham, AL 35233, USA.
³ Asheville Cardiology Associates, 5 Vanderbilt Park Drive, Asheville, NC 28803, USA.
⁴ University of Alabama at Birmingham, 619 19th Street South JT 777, Birmingham, AL 35249, USA. Electronic address: pbhambhvani@uabmc.edu.

PMID: 34392922
DOI: 10.1016/j.rcl.2021.05.009

Abstract

Cardiovascular disease is the leading cause of death worldwide. Given the increased availability of radiopharmaceuticals, improved positron emission tomography (PET) camera systems and proven higher diagnostic accuracy, PET is increasingly utilized in the management of various cardiovascular diseases. PET has high temporal and spatial resolution, when compared to Single Photon Emission Computed Tomography. In clinical practice, hybrid imaging with sequential PET and Computed Tomography acquisitions (PET/CT) or concurrent PET and Magnetic Resonance Imaging are standard. This article will review applications of cardiovascular PET/CT including myocardial perfusion, viability, cardiac sarcoidosis/inflammation, and infection.

Keywords: Infection; PET Cardiac; Perfusion; Sarcoidosis; Viability.

Publication types

Review

MeSH terms

Cardiomyopathies / diagnostic imaging
Cardiovascular Diseases / diagnostic imaging*
Fluorodeoxyglucose F18
Humans
Myocardial Perfusion Imaging / trends*
Myocarditis / diagnostic imaging
Positron-Emission Tomography / trends*
Radiopharmaceuticals
Sarcoidosis / diagnostic imaging

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18